Systemic Sclerosis : : An Update on the Aberrant Immune System and Clinical Features / / edited by Timothy Radstake.

Systemic sclerosis (SSc), or often referred to as Scleroderma (tight skin), is characterized by an exaggerated formation of collagen fibers in the skin, which leads to fibrosis. Accumulating evidence now points toward three pathological hallmarks that are implicated in Ssc, the order of which has ye...

Full description

Saved in:
Bibliographic Details
TeilnehmendeR:
Place / Publishing House:[Place of publication not identified] : : InTech,, 2012.
Year of Publication:2012
Language:English
Physical Description:1 online resource (220 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993548105804498
ctrlnum (CKB)3230000000077059
(NjHacI)993230000000077059
(oapen)https://directory.doabooks.org/handle/20.500.12854/65521
(EXLCZ)993230000000077059
collection bib_alma
record_format marc
spelling Radstake, Timothy edt
Systemic Sclerosis : An Update on the Aberrant Immune System and Clinical Features / edited by Timothy Radstake.
Systemic sclerosis
IntechOpen 2012
[Place of publication not identified] : InTech, 2012.
1 online resource (220 pages)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on: online resource; title from PDF information screen (InTech, viewed October 22, 2022).
Includes bibliographical references and index.
Systemic sclerosis (SSc), or often referred to as Scleroderma (tight skin), is characterized by an exaggerated formation of collagen fibers in the skin, which leads to fibrosis. Accumulating evidence now points toward three pathological hallmarks that are implicated in Ssc, the order of which has yet to be determined: endothelial dysfunction, autoantibody formation, and activation of fibroblasts. This current book provides up-to-date information on the pathogenesis and clinical features of this severe syndrome. It is our hope that this book will aid both clinicians and researchers in dealing with patients with this clinical syndrome. In addition, we hope to shed more light on this rare and severely disabling syndrome, ultimately leading to better research and successful therapeutic targeting.
English
Immunology.
Immunology
953-307-869-3
Radstake, Timothy, editor.
language English
format eBook
author2 Radstake, Timothy,
author_facet Radstake, Timothy,
author2_variant t r tr
t r tr
author2_role TeilnehmendeR
title Systemic Sclerosis : An Update on the Aberrant Immune System and Clinical Features /
spellingShingle Systemic Sclerosis : An Update on the Aberrant Immune System and Clinical Features /
title_sub An Update on the Aberrant Immune System and Clinical Features /
title_full Systemic Sclerosis : An Update on the Aberrant Immune System and Clinical Features / edited by Timothy Radstake.
title_fullStr Systemic Sclerosis : An Update on the Aberrant Immune System and Clinical Features / edited by Timothy Radstake.
title_full_unstemmed Systemic Sclerosis : An Update on the Aberrant Immune System and Clinical Features / edited by Timothy Radstake.
title_auth Systemic Sclerosis : An Update on the Aberrant Immune System and Clinical Features /
title_alt Systemic sclerosis
title_new Systemic Sclerosis :
title_sort systemic sclerosis : an update on the aberrant immune system and clinical features /
publisher IntechOpen
InTech,
publishDate 2012
physical 1 online resource (220 pages)
isbn 953-51-6737-5
953-307-869-3
callnumber-first Q - Science
callnumber-subject QR - Microbiology
callnumber-label QR181
callnumber-sort QR 3181 S978 42012
illustrated Not Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 616 - Diseases
dewey-full 616.079
dewey-sort 3616.079
dewey-raw 616.079
dewey-search 616.079
work_keys_str_mv AT radstaketimothy systemicsclerosisanupdateontheaberrantimmunesystemandclinicalfeatures
AT radstaketimothy systemicsclerosis
status_str n
ids_txt_mv (CKB)3230000000077059
(NjHacI)993230000000077059
(oapen)https://directory.doabooks.org/handle/20.500.12854/65521
(EXLCZ)993230000000077059
carrierType_str_mv cr
is_hierarchy_title Systemic Sclerosis : An Update on the Aberrant Immune System and Clinical Features /
author2_original_writing_str_mv noLinkedField
_version_ 1787548700973727744
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02173nam a2200397 i 4500</leader><controlfield tag="001">993548105804498</controlfield><controlfield tag="005">20231116231033.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">221022s2012 xx ob 001 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">953-51-6737-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)3230000000077059</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)993230000000077059</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/65521</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)993230000000077059</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QR181</subfield><subfield code="b">.S978 2012</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.079</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Radstake, Timothy</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Systemic Sclerosis :</subfield><subfield code="b">An Update on the Aberrant Immune System and Clinical Features /</subfield><subfield code="c">edited by Timothy Radstake.</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Systemic sclerosis</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">IntechOpen</subfield><subfield code="c">2012</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">[Place of publication not identified] :</subfield><subfield code="b">InTech,</subfield><subfield code="c">2012.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (220 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on: online resource; title from PDF information screen (InTech, viewed October 22, 2022).</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Systemic sclerosis (SSc), or often referred to as Scleroderma (tight skin), is characterized by an exaggerated formation of collagen fibers in the skin, which leads to fibrosis. Accumulating evidence now points toward three pathological hallmarks that are implicated in Ssc, the order of which has yet to be determined: endothelial dysfunction, autoantibody formation, and activation of fibroblasts. This current book provides up-to-date information on the pathogenesis and clinical features of this severe syndrome. It is our hope that this book will aid both clinicians and researchers in dealing with patients with this clinical syndrome. In addition, we hope to shed more light on this rare and severely disabling syndrome, ultimately leading to better research and successful therapeutic targeting.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Immunology.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Immunology</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">953-307-869-3</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Radstake, Timothy,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">VIDEO</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-11-18 07:47:07 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2012-12-09 08:17:33 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338704230004498&amp;Force_direct=true</subfield><subfield code="Z">5338704230004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338704230004498</subfield></datafield></record></collection>